The relevance of epidemic ET-12 B. cenocepacia lipopolysaccharide (LPS) structure and cytokine induction capacity compared to other burkholderia cepacia complex species Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006
Immunomodulatory effects of feeding with bifidobacterium longum on allergen induced lung inflammation Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009
Anti-inflammatory effect of the combination of a long acting β2-agonist (salmeterol) and a corticosteroid (fluticasone propionate) on human airway epithelial cells following staphylococcus aureus virulence factors challenge Source: Eur Respir J 2006; 28: Suppl. 50, 104s Year: 2006
Inhaled phage therapy for the treatment of acute Pseudomonas aeruginosa lung infections Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018
The functional role of IgE to staphylococcus aureus enterotoxins in severe asthma Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019
Development of an innovative, Staphylococcus aureus enterotoxin B (SEB)-aided rat model of atopic asthma Source: International Congress 2017 – Animal models of asthma and allergies Year: 2017
Pseudomonas aeruginosa in patients with cystic fibrosis - a comparison of early eradication and conventional therapySource: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004
Nebulized heparin in Burkholderia cepacia colonized adult cystic fibrosis patients Source: Eur Respir J 2001; 17: 36-38 Year: 2001
Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledgeSource: Eur Respir J, 55 (4) 1901592; 10.1183/13993003.01592-2019 Year: 2020
The role of MBL in B. cepacia infections in CF patients Source: Eur Respir J 2005; 26: Suppl. 49, 403s Year: 2005
Kocuria species: an emerging bacterial infection in critical ill patients Source: International Congress 2019 – CCC Respiratory critical care Year: 2019
Enhance protection against nasopharyngeal carriage of Streptococcus pneumoniae elicited by live recombinant attenuated oral salmonella vaccines with PspA‘ and PsaA Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009
Bacterial killing is enhanced after exogenous administration of lysozyme in the lungs Source: Eur Respir J 2001; 18: Suppl. 33, 9s Year: 2001
Use of streptococcus antigen's express-diagnostic test for rational antibiotic therapy in patients with pharyngitis Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002
Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis Source: Eur Respir J , 49 (4) 1600851; DOI: 10.1183/13993003.00851-2016 Year: 2017
Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa Source: Eur Respir J, 55 (3) 1802456; 10.1183/13993003.02456-2018 Year: 2020
LATE-BREAKING ABSTRACT: Distinct bacterial species: Escherichia coli and staphylococcus aureus have specific microcalorimetric patterns Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012
Stating the obvious: intravenous magnesium sulphate should be the first parenteral bronchodilator in paediatric asthma exacerbations unresponsive to first-line therapy Source: Breathe, 17 (4) 210113; 10.1183/20734735.0113-2021 Year: 2021
The impact of sensitization to Staphylococcus aureus–derived enterotoxins on allergic and respiratory disorders Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020
PcrV antibody prophylaxis in combination with antibiotic therapy reduces lung injury and improves survival in pseudomonas aeruginosa infected mice Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011